The association between wearable activity monitor metrics and performance status in oncology: a systematic review

Milan Kos1, Esther N. Pijnappel1, Laurien M. Buffart2, Britt R. Balvers1, Caroline S. Kampshoff3, Johanna W. Wilmink1, Hanneke W. M. van Laarhoven3, Martijn G.H. van Oijen1
1Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
2Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Philips van Leydenlaan 15, Nijmegen, The Netherlands
3Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands

Tóm tắt

Abstract Purpose

The expanding armamentarium of wearable activity monitors (WAMs) offers new opportunities to supplement physician-assessed performance status (PS) with real-life patient activity data. These data could guide clinical decision making or serve as a measure of treatment outcome. However, information on the association between physical activity (PA) and sedentary behavior (SB) monitored with wearables (i.e., WAM metrics) and PS in patients with cancer is needed. Therefore, we conducted a systematic review to examine the association between WAM metrics and PS in patients with cancer.

Methods

We searched MEDLINE and Embase for studies that assessed the association between WAM metrics and performance status among adults with cancer. We extracted information on study design and population, WAM type and different activity metrics, outcome definitions, and results. Included studies were subjected to risk of bias assessment and subsequent best evidence synthesis.

Results

Fourteen studies were included in this review. All studies reported on different combinations of WAM metrics including: daily steps (n = 8), SB (n = 5), mean activity counts (n = 4), dichotomous circadian rest-activity index (n = 3), and time spent in moderate-to-vigorous PA (MVPA) (n = 3). Much heterogeneity was observed regarding study population, WAM used, and reporting of results. We found moderate evidence for a positive weak-to-moderate association between WAM-assessed PA and PS and a weak-to-moderate negative association between WAM-assessed SB metrics and PS.

Conclusion

Weak-to-moderate associations between WAM metrics and PS suggest that WAM data and physician-assessed PS cannot be used interchangeably. Instead, WAM data could serve as a dynamic and objective supplement measurement of patients’ physical performance.

Từ khóa


Tài liệu tham khảo

Sargent DJ, Köhne CH, Sanoff HK et al (2009) Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer. J Clin Oncol 27:1948–1955

Mol L, Ottevanger PB, Koopman M, Punt CJA (2016) The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients. Eur J Cancer 66:138–143

ter Veer E, van Kleef JJ, Schokker S et al (2018) Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: a systematic review and meta-analysis. Eur J Cancer 103:214–226

ter Veer E, van Rijssen LB, Besselink MG et al (2018) Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease. Lancet Oncol 19:e151–e160

Karnofsky D, Burchenal J (1949) In CM MacLeod (Ed.), Evaluation of chemotherapeutic agents. undefined

Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–656

Kelly CM, Shahrokni A (2016) Moving beyond Karnofsky and ECOG performance status assessments with new technologies. J Oncol 2016:6186543

Myers J, Gardiner K, Harris K et al (2010) Evaluating correlation and interrater reliability for four performance scales in the palliative care setting. J Pain Symptom Manag 39:250–258

Blagden SP, Charman SC, Sharples LD et al (2003) Performance status score: do patients and their oncologists agree? Brit J Cancer 89:1022

Taylor AE, Olver IN, Sivanthan T et al (1999) Observer error in grading performance status in cancer patients. Support Care Cancer 7:332–335

Chow R, Chiu N, Bruera E et al (2016) Inter-rater reliability in performance status assessment among health care professionals: a systematic review. Ann Palliat Medicine 5:83–92

Ando M, Ando Y, Hasegawa Y et al (2001) Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Brit J Cancer 85:1634–1639

Sallis JF, Saelens BE (2000) Assessment of physical activity by self-report: status, limitations, and future directions. Res Q Exercise Sport 71:1–14

Scott JM, Stene G, Edvardsen E, Jones LW (2020) Performance status in cancer: not broken, but time for an upgrade? J Clin Oncol 38:2824–2829

ter Veer E, Mohammad NH, van Valkenhoef G et al (2016) The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis. J Natl Cancer I 108:djw166

Mohammad NH, ter Veer E, Ngai L et al (2015) Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis. Cancer Metastasis Rev 34:429–441

Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341

Burda BU, O’Connor EA, Webber EM et al (2017) Estimating data from figures with a web-based program: considerations for a systematic review. Res Synth Methods 8:258–262

Drevon D, Fursa SR, Malcolm AL (2017) Intercoder reliability and validity of WebPlotDigitizer in extracting graphed data. Behav Modif 41:323–339

Moeyaert M, Maggin D, Verkuilen J (2016) Reliability, validity, and usability of data extraction programs for single-case research designs. Behav Modif 40:874–900

Evans JD (1996) Straightforward statistics for the behavioral sciences. Thomson Brooks/Cole Publishing Co., Pacific Grove

Hayden JA, Côté P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144:427

Kampshoff CS, Jansen F, van Mechelen W et al (2014) Determinants of exercise adherence and maintenance among cancer survivors: a systematic review. Int J Behav Nutr Phy 11:80

Füzéki E, Engeroff T, Banzer W (2017) Health benefits of light-intensity physical activity: a systematic review of accelerometer data of the National Health and Nutrition Examination Survey (NHANES). Sports Med 47:1769–1793

Chinapaw MJM, Proper KI, Brug J et al (2011) Relationship between young peoples’ sedentary behaviour and biomedical health indicators: a systematic review of prospective studies. Obes Rev 12:e621–e632

Cliff DP, Hesketh KD, Vella SA et al (2016) Objectively measured sedentary behaviour and health and development in children and adolescents: systematic review and meta-analysis. Obes Rev 17:330–344

Uijtdewilligen L, Nauta J, Singh AS et al (2011) Determinants of physical activity and sedentary behaviour in young people: a review and quality synthesis of prospective studies. Brit J Sport Med 45:896

van Nieuwenhuizen AJ, Buffart LM, Brug J et al (2015) The association between health related quality of life and survival in patients with head and neck cancer: a systematic review. Oral Oncol 51:1–11

Roscoe JA, Morrow GR, Hickok JT et al (2002) Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 10:329–336

Mormont MC, Waterhouse J, Bleuzen P et al (2000) Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6:3038–3045

Innominato PF, Focan C, Gorlia T et al (2009) Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res 69:4700–4707

Lévi F, Dugué P-A, Innominato P et al (2014) Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int 31:891–900

Gresham G, Hendifar AE, Spiegel B et al (2018) Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients. Npj Digital Medicine 1:27. https://doi.org/10.1038/s41746-018-0032-6

Gupta A, Stewart T, Bhulani N et al (2018) Feasibility of wearable physical activity monitors in patients with cancer. Jco Clin Cancer Informatics 2018:1–10

Broderick JE, May M, Schwartz JE et al (2019) Patient reported outcomes can improve performance status assessment: a pilot study. J Patient-reported Outcomes 3:41

Fujisawa D, Temel JS, Greer JA et al (2019) Actigraphy as an assessment of performance status in patients with advanced lung cancer. Palliat Supportive Care 17:574–578

Ohri N, Halmos B, Bodner WR et al (2019) Daily step counts: a new prognostic factor in locally advanced non-small cell lung cancer? Int J Radiat Oncol Biology Phys 105:745–751

Ferriolli E, Skipworth RJE, Hendry P et al (2012) Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy? J Pain Symptom Manag 43:1025–1035

Maddocks M, Wilcock A (2012) Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure. Support Care Cancer 20:1113–1116

Dennett AM, Peiris CL, Shields N et al (2018) Cancer survivors awaiting rehabilitation rarely meet recommended physical activity levels. Rehabilitation Oncol 36:214–222

Jeffery E, Lee YCG, McVeigh J et al (2017) Feasibility of objectively measured physical activity and sedentary behavior in patients with malignant pleural effusion. Support Care Cancer 25:3133–3141

Broderick JM, Hussey J, Kennedy MJ, Donnell DMO (2014) Patients over 65 years are assigned lower ECOG PS scores than younger patients, although objectively measured physical activity is no different. J Geriatr Oncol 5:49–56

Ohri N, Kabarriti R, Bodner WR et al (2017) Continuous activity monitoring during concurrent chemoradiotherapy. Int J Radiat Oncol Biology Phys 97:1061–1065

Dorion V, Lambert L, Frazzi A et al (2017) A pilot study in the use of activity trackers for assessing response to palliative radiotherapy. Cureus 9:e1871

Soto-Perez-De-Celis E, Kim H, Rojo-Castillo MP et al (2018) A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico. J Geriatr Oncol 9:145–151

Nilanon T, Nocera LP, Martin AS et al (2020) Use of wearable activity tracker in patients with cancer undergoing chemotherapy: toward evaluating risk of unplanned health care encounters. Jco Clin Cancer Informatics 4:839–853

Wright AA, Raman N, Staples P et al (2018) The HOPE pilot study: harnessing patient-reported outcomes and biometric data to enhance cancer care. Jco Clin Cancer Informatics 2018:1–12

Lee PH (2013) Data imputation for accelerometer-measured physical activity: the combined approach. Am J Clin Nutrition 97:965–971

Stephens S, Beyene J, Tremblay MS et al (2018) Strategies for dealing with missing accelerometer data. Rheum Dis Clin N Am 44:317–326

Freedson PS, Melanson E, Sirard J (1998) Calibration of the Computer Science and Applications. Inc accelerometer Medicine Sci Sports Exerc 30:777–781

Matthews CE, Chen KY, Freedson PS et al (2008) Amount of time spent in sedentary behaviors in the United States, 2003–2004. Am J Epidemiol 167:875–881

Tudor-Locke C, Craig CL, Aoyagi Y et al (2011) How many steps/day are enough? For older adults and special populations. Int J Behav Nutr Phy 8:80